Cloud-clone
SKU:LMB833Ra
Magnetic Luminex Assay Kit for Complement Factor D (CFD) ,etc.
Magnetic Luminex Assay Kit for Complement Factor D (CFD) ,etc.
Couldn't load pickup availability
Product No.
LMB833Ra
Organism Species
Rattus norvegicus (Rat).
Sample Type
Serum, plasma and other biological fluids.
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.05-50ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.017 ng/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Complement Factor D (CFD) ,etc..
No significant cross-reactivity or interference between Complement Factor D (CFD) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Complement Factor D (CFD) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Complement Factor D (CFD) ,etc. in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 98-105 | 102 |
| EDTA plasma(n=5) | 82-99 | 95 |
| heparin plasma(n=5) | 88-98 | 92 |
| sodium citrate plasma(n=5) | 80-102 | 85 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Complement Factor D (CFD) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Complement Factor D (CFD) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Complement Factor D (CFD) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 83-93% | 80-98% | 82-104% | 90-98% |
| EDTA plasma(n=5) | 78-101% | 91-103% | 87-98% | 79-101% |
| heparin plasma(n=5) | 83-105% | 86-95% | 89-105% | 83-94% |
| sodium citrate plasma(n=5) | 84-101% | 87-103% | 91-98% | 80-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:CFD) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
| Magazine | Citations |
| Journal of Diabetes Investigation | Relationship between serum adipsin and the first phase of glucose‐stimulated insulin secretion in individuals with different glucose tolerance Pubmed:29432659 |
| Endocrine Practice | CORRELATION OF INCREASED SERUM ADIPSIN WITH INCREASED CARDIOVASCULAR RISKS IN ADULT PATIENTS WITH GROWTH HORMONE DEFICIENCY Pubmed: 30657359 |
| BMC Endocrine Disorders | Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study Pubmed: 31651303 |
| Scientific Reports | HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse Pubmed: 33067533 |
| Biomedicine & Pharmacotherapy | Body fat distribution and circulating adipsin are related to metabolic risks in adult patients with newly diagnosed growth hormone deficiency and improve after … Pubmed: 33254428 |
| Nephrol Dial Transplant | Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis 33367879 |
| Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
| RPB833Ra01 | Recombinant Complement Factor D (CFD) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB833Ra01 | Polyclonal Antibody to Complement Factor D (CFD) | WB; IHC; ICC; IP. |
| MAB833Ra21 | Monoclonal Antibody to Complement Factor D (CFD) | WB; IHC; ICC; IP. |
| SEB833Ra | ELISA Kit for Complement Factor D (CFD) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB833Ra | Magnetic Luminex Assay Kit for Complement Factor D (CFD) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
